Jiangsu Jubang Pharmaceutical

Jiangsu Jubang Pharmaceutical is a prominent Chinese pharmaceutical manufacturing entity and a wholly-owned subsidiary of Hansoh Pharmaceutical Group. Based in the Lianyungang Economic and Technological Development Zone, the company operates large-scale, GMP-compliant facilities focused on the production of Active Pharmaceutical Ingredients (APIs) and oral solid dosages. Its operations support a broad portfolio of therapies in oncology, central nervous system disorders, anti-infectives, and metabolic diseases. The company plays a strategic role in Hansoh's vertical integration, ensuring high-quality production standards for both domestic and international markets. As a core industrial base, it facilitates the transition of innovative R&D programs into commercial-scale supply.